Chongren Wang

813 total citations
24 papers, 544 citations indexed

About

Chongren Wang is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Chongren Wang has authored 24 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Chongren Wang's work include Management of metastatic bone disease (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). Chongren Wang is often cited by papers focused on Management of metastatic bone disease (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). Chongren Wang collaborates with scholars based in China, United States and United Kingdom. Chongren Wang's co-authors include Qunxiong Pan, Jianhua Zhang, Zhengdong Cai, Wei Sun, Yingqi Hua, Hongsheng Wang, Fei Yin, Dongqing Zuo, Zhuoying Wang and Mengxiong Sun and has published in prestigious journals such as Nature Medicine, International Journal of Cancer and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Chongren Wang

24 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chongren Wang China 12 241 235 149 118 110 24 544
Zhiguo Luo China 16 276 1.1× 240 1.0× 172 1.2× 93 0.8× 53 0.5× 60 571
Luckson Mathieu United States 8 290 1.2× 157 0.7× 254 1.7× 75 0.6× 87 0.8× 12 526
Marina Ichetovkin United States 5 202 0.8× 319 1.4× 109 0.7× 124 1.1× 67 0.6× 6 632
Toru Hanamura Japan 14 203 0.8× 151 0.6× 121 0.8× 106 0.9× 63 0.6× 38 500
Chun‐Chieh Wu Taiwan 12 200 0.8× 187 0.8× 171 1.1× 87 0.7× 77 0.7× 32 466
Liangcai Wu China 15 166 0.7× 277 1.2× 128 0.9× 200 1.7× 90 0.8× 24 635
Elisabeth Smolle Austria 12 146 0.6× 329 1.4× 154 1.0× 237 2.0× 73 0.7× 21 639
Yongping Xu China 13 289 1.2× 377 1.6× 231 1.6× 167 1.4× 87 0.8× 26 800
Andrea Pretta Italy 12 272 1.1× 182 0.8× 102 0.7× 139 1.2× 61 0.6× 47 478
Liuxin Cai China 10 208 0.9× 381 1.6× 157 1.1× 205 1.7× 146 1.3× 18 712

Countries citing papers authored by Chongren Wang

Since Specialization
Citations

This map shows the geographic impact of Chongren Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chongren Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chongren Wang more than expected).

Fields of papers citing papers by Chongren Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chongren Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chongren Wang. The network helps show where Chongren Wang may publish in the future.

Co-authorship network of co-authors of Chongren Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chongren Wang. A scholar is included among the top collaborators of Chongren Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chongren Wang. Chongren Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Haoyu, Bing‐Hui Yang, Jiakang Shen, et al.. (2024). Magnetically driven hydrogel microrobots for enhancing the therapeutic effect of anlotinib on osteosarcoma. Frontiers in Bioengineering and Biotechnology. 12. 1409988–1409988. 1 indexed citations
2.
Wang, Hongsheng, Zhuoying Wang, Tao Zhang, et al.. (2022). Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity. Cell & Bioscience. 12(1). 169–169. 6 indexed citations
3.
Zuo, Dongqing, Mengxiong Sun, Haoran Mu, et al.. (2022). O-arm-guided percutaneous microwave ablation and cementoplasty for the treatment of pelvic acetabulum bone metastasis. Frontiers in Surgery. 9. 929044–929044. 1 indexed citations
4.
5.
Sun, Mengxiong, Dongqing Zuo, Hongsheng Wang, et al.. (2021). Surgical Treatment of Sacral Metastatic Tumors. Frontiers in Oncology. 11. 640933–640933. 9 indexed citations
6.
Wang, Zhuoying, Chongren Wang, Dongqing Zuo, et al.. (2019). Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A. International Journal of Biological Sciences. 15(3). 668–679. 30 indexed citations
7.
Sun, Hang, Jianjun Wang, Emma Zhang, et al.. (2019). The differences between gonadal and extra-gonadal malignant teratomas in both genders and the effects of chemotherapy. BMC Cancer. 19(1). 408–408. 3 indexed citations
8.
Wang, Gangyang, Mengxiong Sun, Yafei Jiang, et al.. (2019). Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma. International Journal of Cancer. 145(4). 979–993. 107 indexed citations
9.
Wang, Hongsheng, Wei Sun, Mengxiong Sun, et al.. (2018). HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(5). 1839–1849. 22 indexed citations
10.
Chen, Zhengqi, Chongren Wang, Xiaojun Ma, et al.. (2018). Evaluation of Quality of Life Using EORTC QLQ‐BM22 in Patients with Bone Metastases after Treatment with Magnetic Resonance Guided Focused Ultrasound. Orthopaedic Surgery. 10(3). 264–271. 5 indexed citations
11.
Pan, Qunxiong, et al.. (2017). Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma. Molecular and Clinical Oncology. 6(4). 566–574. 23 indexed citations
12.
Sun, Wei, et al.. (2016). Surgical Treatment of Sacral Neurogenic Tumor: A 10‐year Experience with 64 Cases. Orthopaedic Surgery. 8(2). 162–170. 19 indexed citations
13.
Wang, Chongren, Zhengqi Chen, Wei Sun, et al.. (2016). Palliative treatment of pelvic bone tumors using radioiodine (125I) brachytherapy. World Journal of Surgical Oncology. 14(1). 294–294. 12 indexed citations
14.
Sun, Wei, Xiaojun Ma, Jiakang Shen, et al.. (2016). Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma. International Journal of Molecular Medicine. 38(2). 466–474. 12 indexed citations
15.
Wang, Zhuoying, Chongren Wang, Zifei Zhou, et al.. (2016). CD151-mediated adhesion is crucial to osteosarcoma pulmonary metastasis. Oncotarget. 7(37). 60623–60638. 18 indexed citations
16.
Pan, Qunxiong, et al.. (2015). A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer. OncoTargets and Therapy. 8. 1375–1375. 72 indexed citations
17.
Pan, Qunxiong, et al.. (2014). The Glasgow Prognostic Score Is an Independent Prognostic Predictor of Hepatocellular Carcinoma Following Radical Resection. Oncology Research and Treatment. 37(4). 192–197. 11 indexed citations
18.
Liu, Chen, Rachid Karam, Yingqi Zhou, et al.. (2014). The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma. Nature Medicine. 20(6). 596–598. 99 indexed citations
19.
Zhao, Yifan, Chongren Wang, Yanming Wu, et al.. (2011). P21 (waf1/cip1) is required for non-small cell lung cancer sensitive to Gefitinib treatment. Biomedicine & Pharmacotherapy. 65(3). 151–156. 27 indexed citations
20.
Wang, Chongren, Bin Liu, Ganglin Xue, et al.. (2005). Structure and Magnetic Properties of Pyridine Coordinated Sandwich‐type Heteropolyanion {[Na(H2O)2]3[Ni(C5H5N)]3(AsW9O33)2}9−. Chinese Journal of Chemistry. 23(10). 1412–1416. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiguo Luo Breakdown of academic impact, for papers by Luckson Mathieu Breakdown of academic impact, for papers by Marina Ichetovkin Breakdown of academic impact, for papers by Toru Hanamura Breakdown of academic impact, for papers by Chun‐Chieh Wu Breakdown of academic impact, for papers by Liangcai Wu Breakdown of academic impact, for papers by Elisabeth Smolle Breakdown of academic impact, for papers by Yongping Xu Breakdown of academic impact, for papers by Andrea Pretta Breakdown of academic impact, for papers by Liuxin Cai
Rankless by CCL
2026